Amriti R Lulla - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Cancer Research|August 26, 2024

Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast CancerMi Li, Amriti R Lulla, Yan Wang, et al.

Plos One|August 3, 2017

Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumorsVarun V Prabhu, Amriti R Lulla, Neel S Madhukar, et al.

Cell Cycle (Georgetown, Tex.)|November 22, 2017

Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignanciesVarun V Prabhu, Mala K Talekar, Amriti R Lulla, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Cancer Research|August 26, 2024

Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast CancerMi Li, Amriti R Lulla, Yan Wang, et al.

Plos One|August 3, 2017

Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumorsVarun V Prabhu, Amriti R Lulla, Neel S Madhukar, et al.

Cell Cycle (Georgetown, Tex.)|November 22, 2017

Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignanciesVarun V Prabhu, Mala K Talekar, Amriti R Lulla, et al.

Pageof 2